Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders ; volume:4 ; number:1 ; day:1 ; month:7 ; year:2024 ; pages:1-19 ; date:12.2024
Discover mental health ; 4, Heft 1 (1.7.2024), 1-19, 12.2024
- Creator
-
Juneja, Keshav
Afroze, Sabah
Goti, Zeel
Sahu, Sweta
Asawa, Shivani
Bhuchakra, Hamsa Priya
Natarajan, Balaganesh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44192-024-00077-2
- URN
-
urn:nbn:de:101:1-2409202119006.171858264847
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Juneja, Keshav
- Afroze, Sabah
- Goti, Zeel
- Sahu, Sweta
- Asawa, Shivani
- Bhuchakra, Hamsa Priya
- Natarajan, Balaganesh
- SpringerLink (Online service)
Other Objects (12)
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
EEG-vigilance regulation is associated with and predicts ketamine response in major depressive disorder
Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs
Oral ketamine may offer a solution to the ketamine conundrum
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
How to misuse echo contrast
Trihexyphenidyl Misuse in Delusional Disorder
Impact factor: Use and misuse
Synthesis of Anesthetic Ketamine
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
EEG-vigilance regulation is associated with and predicts ketamine response in major depressive disorder
Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs
Oral ketamine may offer a solution to the ketamine conundrum
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
How to misuse echo contrast
Trihexyphenidyl Misuse in Delusional Disorder
Impact factor: Use and misuse
Synthesis of Anesthetic Ketamine
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats
The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
EEG-vigilance regulation is associated with and predicts ketamine response in major depressive disorder
Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine-lidocaine infusions in conscious dogs
Oral ketamine may offer a solution to the ketamine conundrum
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
How to misuse echo contrast
Trihexyphenidyl Misuse in Delusional Disorder
Impact factor: Use and misuse
Synthesis of Anesthetic Ketamine
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder